Boston Advisors’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$1.82M Buy
21,444
+8,214
+62% +$732K 0.1% 266
2019
Q2
$1.39M Hold
13,230
0.07% 280
2019
Q1
$1.4M Sell
13,230
-30
-0.2% -$3.01K 0.07% 281
2018
Q4
$1.11M Sell
13,260
-900
-6% -$81.5K 0.06% 294
2018
Q3
$1.44M Sell
14,160
-455
-3% -$43.9K 0.06% 315
2018
Q2
$1.18M Sell
14,615
-220
-1% -$17.5K 0.03% 347
2018
Q1
$1.09M Buy
14,835
+700
+5% +$52.4K 0.03% 351
2017
Q4
$996K Buy
+14,135
New +$1.02M 0.02% 367

Other funds holding NGVT

Boston Advisors's NGVT Position: Q3 2019 in Review

Boston Advisors increased its Ingevity (NGVT) stake by 62% in Q3 2019, buying an estimated $732K and bringing the position to 21,444 shares worth $1.82M. The position accounts for 0.1% of the portfolio, ranked #266.

Boston Advisors first reported a position in NGVT in Q4 2017 and has held it in 8 quarters since. 335 funds tracked by Wall St. Rank hold NGVT as of Q3 2019.

  • Boston Advisors held 21,444 shares of Ingevity worth $1.82M as of Q3 2019.
  • Boston Advisors bought 8,214 Ingevity shares in Q3 2019, an estimated $732K.
  • Ingevity made up 0.1% of Boston Advisors's portfolio in Q3 2019, its #266 holding.
  • Boston Advisors first reported a position in Ingevity in Q4 2017 and has held it in 8 quarters since.
  • 335 funds tracked by Wall St. Rank held Ingevity as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.